ATRIANCE Side Effects

7010337-8 | Myelitis, Neurotoxicity, Paraesthesia
on Sep 15, 2010 Male patient from ITALY , 40 years of age, was treated with Atriance (View Usage). Patient experienced the following unwanted or unexpected effects: myelitis, neurotoxicity, paraesthesia. Atriance dosage: .

6956423-X | Blood Creatine Phosphokinase Increased, Hypophosphataemia, Muscle Spasms, Myalgia, Myositis
Patient was taking Atriance (View Usage). Patient had the following side effects: blood creatine phosphokinase increased, hypophosphataemia, muscle spasms, myalgia, myositis (What is myositis?) on Aug 19, 2010 from FRANCE Additional patient health information: Female patient , 15 years of age, . Atriance dosage: 650mgm2 Cyclic. During the same period patient was treated with BACTRIM (View Bactrim Review and Bactrim Label ). Patient was hospitalized.

6848210-8 | Cardiotoxicity, Ejection Fraction Decreased, Left Ventricular Failure, Pulmonary Oedema
Adverse event was reported on Jul 09, 2010 by a Male patient taking Atriance (View Usage) (Dosage: ) . Location: RUSSIAN FEDERATION , child 8 years of age, After Atriance was administered, patient had the following side effects: cardiotoxicity, ejection fraction decreased, left ventricular failure, pulmonary oedema. Patient was hospitalized.

6761066-7 | Constipation, Diplegia, Extensor Plantar Response, Gait Disturbance, Hyporeflexia, Incontinence, Muscular Weakness, Myelopathy, Neurotoxicity
on Jun 01, 2010 Male patient from GREECE , 42 years of age, weighting 165.3 lb, was treated with Atriance (View Usage). Patient experienced the following unwanted or unexpected effects: constipation (What is constipation?), diplegia, extensor plantar response, gait disturbance, hyporeflexia, incontinence, muscular weakness, myelopathy, neurotoxicity. Atriance dosage: 1500mgm2 Per Day. During the same period patient was treated with CLADRIBINE (View Cladribine Review and Cladribine Label ), IFOSFAMIDE (View Ifosfamide Review and Ifosfamide Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.


6744138-2 | Constipation, Diplegia, Extensor Plantar Response, Gait Disturbance, Hyporeflexia, Incontinence, Muscular Weakness, Myelopathy, Neurotoxicity
on May 26, 2010 Male patient from GREECE , 42 years of age, weighting 165.3 lb, was treated with Atriance (View Usage). Patient had the following side effects: constipation (What is constipation?), diplegia, extensor plantar response, gait disturbance, hyporeflexia, incontinence, muscular weakness, myelopathy, neurotoxicity. Atriance dosage: 1500mgm2 Per Day. During the same period patient was treated with CLADRIBINE (View Cladribine Review and Cladribine Label ), IFOSFAMIDE (View Ifosfamide Review and Ifosfamide Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

6730426-2 | Blood Creatinine Increased, Creatinine Renal Clearance Decreased, Dehydration, Infection, Renal Failure Acute, Renal Impairment
Patient was taking Atriance (View Usage). After Atriance was administered, patient had the following side effects: blood creatinine increased, creatinine renal clearance decreased, dehydration, infection (What is infection?), renal failure acute, renal impairment on May 07, 2010 from FRANCE Additional patient health information: Male patient , weighting 172.0 lb, was diagnosed with lymphocytic leukaemia, vomiting, sepsis (What is sepsis?), fluid retention, deep vein thrombosis (What is deep vein thrombosis?) and. Atriance dosage: 1500mgm2 Cyclic. During the same period patient was treated with ZOPHREN (8mg Three Times Per Day) (View Zophren Review and Zophren Label ), AXEPIM (2g Twice Per Day) (View Axepim Review and Axepim Label ), VANCOMYCIN HCL (2g Continuous) (View Vancomycin Hcl Review and Vancomycin Hcl Label ), CIFLOX (400mg Twice Per Day) (View Ciflox Review and Ciflox Label ), LASIX (20mg Per Day) (View Lasix Review and Lasix Label ), HEPARIN (120mg Continuous) (View Heparin Review and Heparin Label ).

6408811-8 | Quadriplegia
Adverse event was reported on Oct 12, 2009 by a Male patient taking Atriance (View Usage) (Dosage: ) . Location: FRANCE , 37 years of age, Patient experienced the following unwanted or unexpected effects: quadriplegia. Patient was hospitalized.

6331055-5 | Acute Respiratory Failure, Automatic Bladder, Condition Aggravated, Guillain-barre Syndrome, Muscular Weakness, Optic Neuropathy, Paraesthesia, Peripheral Sensorimotor Neuropathy, Respiratory Distress
on Aug 19, 2009 Male patient from FRANCE , 13 years of age, was treated with Atriance (View Usage). Patient had the following side effects: acute respiratory failure, automatic bladder, condition aggravated, guillain-barre syndrome (What is guillain-barre syndrome?), muscular weakness, optic neuropathy, paraesthesia, peripheral sensorimotor neuropathy, respiratory distress. Atriance dosage: 665mg Per Day. During the same period patient was treated with ETOPOSIDE (152mg Per Day) (View Etoposide Review and Etoposide Label ), CYCLOPHOSPHAMIDE (480mg Per Day) (View Cyclophosphamide Review and Cyclophosphamide Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), DAUNORUBICIN HCL (View Daunorubicin Hcl Review and Daunorubicin Hcl Label ), ELSPAR (View Elspar Review and Elspar Label ), METHOTREXATE SODIUM (View Methotrexate Sodium Review and Methotrexate Sodium Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), CORTICOSTEROIDS (View Corticosteroids Review and Corticosteroids Label ). Patient was hospitalized.

6327155-6 | Cholestasis, Gamma-glutamyltransferase Increased, Hepatic Steatosis, Hepatocellular Injury, Jaundice, Motor Dysfunction, Ocular Icterus, Peripheral Motor Neuropathy, Rash
on Aug 14, 2009 Male patient from FRANCE , weighting 127.9 lb, was diagnosed with sleep disorder (What is sleep disorder?), prophylaxis against transplant rejection and was treated with Atriance (View Usage). After Atriance was administered, patient had the following side effects: cholestasis, gamma-glutamyltransferase increased, hepatic steatosis, hepatocellular injury, jaundice (What is jaundice?), motor dysfunction, ocular icterus, peripheral motor neuropathy, rash (What is rash?). Atriance dosage: 650mgm2 Per Day. During the same period patient was treated with INEXIUM (40mg Per Day) (View Inexium Review and Inexium Label ), HYDROCORTISONE (10mg Twice Per Day) (View Hydrocortisone Review and Hydrocortisone Label ), LAROXYL (20drop Per Day) (View Laroxyl Review and Laroxyl Label ), BACTRIM (800mg Three Times Per Week) (View Bactrim Review and Bactrim Label ), TOPALGIC ( FRANCE ) (50mg As Required) (View Topalgic ( France ) Review and Topalgic ( France ) Label ), AMOXICILLIN TRIHYDRATE (500mg Per Day) (View Amoxicillin Trihydrate Review and Amoxicillin Trihydrate Label ), PENTACARINAT (1neb Every 3 Weeks) (View Pentacarinat Review and Pentacarinat Label ). Patient was hospitalized.

6294708-3 | Cholestasis, Gamma-glutamyltransferase Increased, Hepatocellular Injury, Jaundice, Neuropathy Peripheral, Ocular Icterus
Patient was taking Atriance (View Usage). Patient experienced the following unwanted or unexpected effects: cholestasis, gamma-glutamyltransferase increased, hepatocellular injury, jaundice (What is jaundice?), neuropathy peripheral, ocular icterus on Jul 24, 2009 from FRANCE Additional patient health information: Male patient , weighting 127.9 lb, was diagnosed with sleep disorder (What is sleep disorder?), prophylaxis against transplant rejection and. Atriance dosage: 650mgm2 Per Day. During the same period patient was treated with NEXIUM (40mg Per Day) (View Nexium Review and Nexium Label ), HYDROCORTISONE (10mg Twice Per Day) (View Hydrocortisone Review and Hydrocortisone Label ), LAROXYL (20drop Per Day) (View Laroxyl Review and Laroxyl Label ), BACTRIM (800mg Three Times Per Week) (View Bactrim Review and Bactrim Label ), TOPALGIC ( FRANCE ) (50mg As Required) (View Topalgic ( France ) Review and Topalgic ( France ) Label ), AMOXICILLIN TRIHYDRATE (500mg Per Day) (View Amoxicillin Trihydrate Review and Amoxicillin Trihydrate Label ), PENTACARINAT (1neb Every 3 Weeks) (View Pentacarinat Review and Pentacarinat Label ).

6272097-8 | Cholestasis, Hepatocellular Injury, Jaundice, Neuropathy Peripheral
Adverse event was reported on Jul 06, 2009 by a Male patient taking Atriance (View Usage) (Dosage: ) . Location: FRANCE , 16 years of age, Patient had the following side effects: cholestasis, hepatocellular injury, jaundice (What is jaundice?), neuropathy peripheral.

6231502-3 | Acute Polyneuropathy, Disease Progression
on Jun 08, 2009 Female patient from UNITED KINGDOM , 55 years of age, was treated with Atriance (View Usage). After Atriance was administered, patient had the following side effects: acute polyneuropathy, disease progression. Atriance dosage: .

5879388-0 | Ataxia, Balance Disorder, Hypoaesthesia, Sensory Disturbance, Spinal Cord Disorder
on Sep 01, 2008 Male patient from FRANCE , child 10 years of age, weighting 83.78 lb, was diagnosed with t-cell type acute leukaemia and was treated with Atriance (View Usage). Patient experienced the following unwanted or unexpected effects: ataxia (What is ataxia?), balance disorder, hypoaesthesia, sensory disturbance, spinal cord disorder. Atriance dosage: 650mgm2 Cyclic. During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), ARACYTINE (View Aracytine Review and Aracytine Label ), CORTICOID (View Corticoid Review and Corticoid Label ), PEGASPARGASE (View Pegaspargase Review and Pegaspargase Label ), MEDICAMENT (View Medicament Review and Medicament Label ). Patient was hospitalized and became disabled.

5856279-2 | Acute Polyneuropathy
Patient was taking Atriance (View Usage). Patient had the following side effects: acute polyneuropathy on Aug 19, 2008 from UNITED KINGDOM Additional patient health information: Female patient , 55 years of age, . Atriance dosage: .

5838705-8 | Axonal Neuropathy, Dysstasia, Encephalopathy, Movement Disorder, Neuropathy Peripheral, Paraesthesia, Peripheral Coldness, Tachycardia
Adverse event was reported on Aug 01, 2008 by a Female patient taking Atriance (View Usage) (Dosage: ) . Location: NETHERLANDS , 15 years of age, weighting 94.80 lb, After Atriance was administered, patient had the following side effects: axonal neuropathy, dysstasia, encephalopathy, movement disorder (What is movement disorder?), neuropathy peripheral, paraesthesia, peripheral coldness, tachycardia. During the same period patient was treated with PREDNISON (5mg Twice Per Day) (View Prednison Review and Prednison Label ), COTRIM (View Cotrim Review and Cotrim Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), SLOW K (600mg Twice Per Day) (View Slow-k Review and Slow-k Label ), AMLODIPINE (7.5mg Twice Per Day) (View Amlodipine Review and Amlodipine Label ), VALCYTE (675mg Twice Per Day) (View Valcyte Review and Valcyte Label ), FLUCONAZOLE (200mg Per Day) (View Fluconazole Review and Fluconazole Label ), MOVICOLON (20g Twice Per Day) (View Movicolon Review and Movicolon Label ). Patient was hospitalized and became disabled.

5780350-7 | Spinal Cord Disorder
on Jun 10, 2008 Female patient from FRANCE , child 10 years of age, was treated with Atriance (View Usage). Patient experienced the following unwanted or unexpected effects: spinal cord disorder. Atriance dosage: .

5749508-7 | Acute Leukaemia, Transaminases Increased
on May 14, 2008 Male patient from FRANCE , 14 years of age, was treated with Atriance (View Usage). Patient had the following side effects: acute leukaemia, transaminases increased. Atriance dosage: .

5716302-2 | Aspartate Aminotransferase Increased, Blood Creatine Phosphokinase Increased, Blood Creatine Phosphokinase Mb Increased, Blood Lactate Dehydrogenase Increased, C-reactive Protein Increased, Hepatic Enzyme Increased, Muscular Weakness, Myalgia, Myoglobin Blood Increased
Patient was taking Atriance (View Usage). After Atriance was administered, patient had the following side effects: aspartate aminotransferase increased, blood creatine phosphokinase increased, blood creatine phosphokinase mb increased, blood lactate dehydrogenase increased, c-reactive protein increased, hepatic enzyme increased, muscular weakness, myalgia, myoglobin blood increased on Apr 22, 2008 from GERMANY Additional patient health information: Male patient , 46 years of age, weighting 163.1 lb, was diagnosed with non-hodgkin's lymphoma and. Atriance dosage: 1500mgm2 Per Day. During the same period patient was treated with IFOSFAMIDE (800mgm2 Per Day) (View Ifosfamide Review and Ifosfamide Label ), SEBIVO (650mg Per Day) (View Sebivo Review and Sebivo Label ), TAVANIC (500mg Per Day) (View Tavanic Review and Tavanic Label ), COTRIM DS (View Cotrim Ds Review and Cotrim Ds Label ), PANTOZOL (View Pantozol Review and Pantozol Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE, GLUCOSE (1.5l Per Day) (View Sodium Chloride, Sodium Bicarbonate, Potassium Chloride, Glucose Review and Sodium Chloride, Sodium Bicarbonate, Potassium Chloride, Glucose Label ). Patient was hospitalized.

5712854-7 | Ataxia, Bladder Disorder, Bone Marrow Transplant, Coordination Abnormal, Csf Protein Increased, Dysaesthesia, Dyspraxia, Monoplegia
Adverse event was reported on Apr 15, 2008 by a Male patient taking Atriance (View Usage) (Dosage: 650mgm2 Per Day) was diagnosed with leukaemia, bone marrow transplant (What is bone marrow transplant?) and. Location: DENMARK , 18 years of age, weighting 165.3 lb, Patient experienced the following unwanted or unexpected effects: ataxia (What is ataxia?), bladder disorder, bone marrow transplant (What is bone marrow transplant?), coordination abnormal, csf protein increased, dysaesthesia, dyspraxia, monoplegia. During the same period patient was treated with FLUDARABINE PHOSPHATE (40mgm2 Per Day) (View Fludarabine Phosphate Review and Fludarabine Phosphate Label ), CYTOSAR (View Cytosar Review and Cytosar Label ), METHOTREXATE (12mg Cyclic) (View Methotrexate Review and Methotrexate Label ), AMSACRINE (200mg Cyclic) (View Amsacrine Review and Amsacrine Label ), DAUNOXOME (117.6mg Cyclic) (View Daunoxome Review and Daunoxome Label ), CRANIAL IRRADIATION (View Cranial Irradiation Review and Cranial Irradiation Label ). Patient was hospitalized and became disabled.

5709618-7 | Ataxia, Dysaesthesia, Dyspraxia, Monoplegia, Myelitis Transverse, Paraesthesia, Paralysis, Peripheral Motor Neuropathy
on Apr 10, 2008 Male patient from DENMARK , 18 years of age, weighting 165.3 lb, was diagnosed with leukaemia, bone marrow transplant (What is bone marrow transplant?) and was treated with Atriance (View Usage). Patient had the following side effects: ataxia (What is ataxia?), dysaesthesia, dyspraxia, monoplegia, myelitis transverse, paraesthesia, paralysis (What is paralysis?), peripheral motor neuropathy. Atriance dosage: 650mgm2 Per Day. During the same period patient was treated with FLUDARABINE PHOSPHATE (40mgm2 Per Day) (View Fludarabine Phosphate Review and Fludarabine Phosphate Label ), CYTOSAR (View Cytosar Review and Cytosar Label ), METHOTREXATE (12mg Cyclic) (View Methotrexate Review and Methotrexate Label ), AMSACRINE (200mg Cyclic) (View Amsacrine Review and Amsacrine Label ), DAUNOXOME (117.6mg Cyclic) (View Daunoxome Review and Daunoxome Label ), CRANIAL IRRADIATION (View Cranial Irradiation Review and Cranial Irradiation Label ). Patient was hospitalized and became disabled.